China Biologic Announces Shareholders Approval of Merger Agreement
News provided by
Share this article
Share this article
BEIJING, March 1, 2021 /PRNewswire/ China Biologic Products Holdings, Inc. (NASDAQ: CBPO, China Biologic or the Company ), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that, at an extraordinary general meeting (the EGM ) held today, the Company s shareholders voted in favor of the proposal to authorize and approve the previously announced agreement and plan of merger, dated as of November 19, 2020 (the Merger Agreement ), among the Company, CBPO Holdings Limited ( Parent ) and CBPO Group Limited ( Merger Sub ), pursuant to which, Merger Sub will be merged with and into the Company with the Company continuing as the surviving company and becoming a wholly owned subsidiary of Parent (the Merger ), the plan of merger (the Plan of Merger ) required to be filed with the Registrar of Companies of the Cayma
Buyer Group Led by Evercel Completes Acquisition of ZAGG
SALT LAKE CITY, Feb. 22, 2021 (GLOBE NEWSWIRE) ZAGG Inc (Nasdaq: ZAGG) (“we,” “us,” “our,” “ZAGG,” or the “Company”), a leading global mobile lifestyle company, today announced the completion of its sale to a buyer group led by Evercel, Inc. (“Evercel”).
The transaction was previously announced on December 11, 2020 and received approval from ZAGG’s stockholders on February 18, 2021. As a result of the completion of the transaction, ZAGG’s stockholders will receive $4.20 per share in cash and a contingent right to receive an additional payment of up to $0.30 per share, and ZAGG’s common stock will cease to trade on the Nasdaq Global Select exchange.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
California BanCorp Appoints Julie Levenson to Board of Directors
California BanCorpFebruary 8, 2021 GMT
OAKLAND, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) California BanCorp (the “Company”) (Nasdaq: CALB), the parent company of California Bank of Commerce (the “Bank”), today announced that Julie J. Levenson has been appointed to the Board of Directors of the Company and the Bank.
Levenson is a career investment banker and financial adviser. She is a founding partner of La Honda Advisors, a Silicon Valley-based boutique advisory firm that provides M&A and capital markets advice to companies in the technology, consumer and health-tech industries. Previously, she served as a managing director of several investment banking firms, including Cowen and Company, Houlihan Lokey, Bear Stearns & Co. and Merrill Lynch.